Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

Completed

• Conditions: Obsessive-Compulsive Disorder
• Interventions: Behavioral: Exposure and response prevention therapy

• Registration Number: NCT04701372
• Lead Sponsor: NOCD

Brief Summary

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-01
• Primary Completion: 2020-11-08
• Study Completion: 2020-11-08
• Status Verified: 2021-01
• Study First Submitted: 2021-01-02
• Study First Submitted QC: 2021-01-07
• Last Update Submitted: 2021-01-07
• Study First Posted: 2021-01-08
• Last Update Posted: 2021-01-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2069

Inclusion Criteria

• obsessive-compulsive disorder

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Obsessive-Compulsive Disorder	Exposure and response prevention therapy	adults, adolescents, and children with obsessive-compulsive disorder

Primary Outcome Measures

Name	Time	Method
Dimensional Obsessive-Compulsive Scale	change from pre-treatment to post-treatment (after 11 weeks)	self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes

Secondary Outcome Measures

Name	Time	Method
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	clinician-rated psychometric instrument to measure overall OCD symptom severity
Depression Anxiety and Stress Scale (DASS-21)	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	self-rated psychometric instrument to measure depression, anxiety, and stress
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	self-rated psychometric instrument to measure quality of life

Trial Locations

Locations (1)

Nocd, Llc; 🇺🇸 Chicago, Illinois, United States